Results 71 to 80 of about 81,312 (206)
Demographic and clinical features of healthy subjects, non-ELS/MDD and ELS/MDD. [PDF]
Non ELS/MDD subjects have no history of childhood abuse; ELS/MDD subjects have history of childhood abuse. ETI, Early Trauma Inventory; SDS, Self-Rating Depression Scale; SAS, Self-Rating Anxiety Scale. a, in years; b, in years; c, in months.
Wuju Li (11171) +7 more
core +1 more source
Association between MDD-related traits in GS:SFHS and UK Biobank with the Psychiatric Genomics Consortium derived MDD polygenic risk scores. [PDF]
Association between MDD-related traits in GS:SFHS and UK Biobank with the Psychiatric Genomics Consortium derived MDD polygenic risk scores.
Eleanor Wigmore (2954115) +22 more
core +1 more source
Jiali Liu,1 Yebao Huang,2 Xiaoshuo Fu,1 Jiali Wei,1 Ping Wei3 1Department of Anorectal Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210023, People’s Republic of China; 2Department of Anorectal Surgery, Liuzhou People’s
Liu J, Huang Y, Fu X, Wei J, Wei P
doaj
Background: Major depressive disorder (MDD) is a well-known psychiatric condition that can affect a diverse range of populations worldwide. Objectives: This research aimed to examine sex differences in hemato-physiological, clinical, and socioeconomic ...
Basim A. Abd +2 more
doaj +1 more source
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) [PDF]
Introduction: MDD is the leading cause of disability worldwide and lack of response to treatment is reported in ~30% of subjects. Pharmacogenomics studies performed so far failed to identify single SNPs with a replicable effect on anti-depressants ...
Minelli Alessandra +4 more
core +1 more source
L’objectif de cet article est de souligner le rôle de la confiance dans l'établissement des interactions réussies et durables entre les distributeurs et les PME fournissant les MDD.
AGZIT FATIMA ZAHRA +2 more
doaj
IntroductionMajor depressive disorder (MDD) exhibits heterogeneity in treatment response.ObjectiveThis exploratory analysis aims to evaluate the differential changes in individual items of the MADRS between melancholic MDD (M-MDD) and unspecified MDD (U ...
Beatriz Pozuelo Moyano +6 more
doaj +1 more source
New and emerging pharmacologic treatments for MDD
Major depressive disorder (MDD) presents a significant global health challenge, characterized by a high prevalence and significant impact on quality of life. Traditional antidepressants fall short in terms of efficacy and onset speed, up to 60% of patients. This review delves into the new and emerging pharmacologic treatments for MDD, focusing on their
Uyar, Aslihan, Gonul, Ali Saffet
openaire +2 more sources
MDD is best predicted using multiple PRS. [PDF]
MDD risk explained (R2 coefficient (%); top bar values) on the liability scale by each PRS in GS:SFHS; weighted by GWAS main additive and GWIS stress-sensitivity effects independently and combined.
Aleix Arnau-Soler (6107084) +3 more
core +1 more source
Visualizing MDD Projects [PDF]
Visualizing information enables humans to capture, understand, and analyze them in an efficient way. Tools providing such visualization possibilities are omnipresent in software develop- ment processes and still subject to current research.
Rumpe, Bernhard +2 more
core

